Gainers

• Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million.
• Cue Biopharma (NASDAQ:CUE) stock moved upwards by 32.25% to $49.0. The company's market cap stands at $269.1 million.
• DataMEDS AI (NASDAQ:MEDS) shares moved upwards by 12.76% to $4.24. The market value of their outstanding shares is at $12.0 million.
• Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 11.53% to $1.74. The market value of their outstanding shares is at $1.0 million.
• Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 11.05% to $2.21. The market value of their outstanding shares is at $4.7 million.
• Invivyd (NASDAQ:IVVD) stock moved upwards by 10.73% to $0.84. The market value of their outstanding shares is at $222.5 million.

Losers

• IM Cannabis (NASDAQ:IMCC) shares decreased by 30.3% to $2.95 during Monday's pre-market session. The company's market cap stands at $2.5 million.
• Aligos Therapeutics (NASDAQ:ALGS) stock decreased by 15.08% to $4.45. The company's market cap stands at $32.7 million.
• Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 13.84% to $1.68. The company's market cap stands at $6.4 million.
• BeyondSpring (NASDAQ:BYSI) stock declined by 13.05% to $0.65. The market value of their outstanding shares is at $30.8 million.
• Palatin Techs (NASDAQ:PTN) shares decreased by 12.53% to $9.5. The market value of their outstanding shares is at $19.3 million.
• Telix Pharmaceuticals (NASDAQ:TLX) stock decreased by 9.46% to $11.4. The market value of their outstanding shares is at $4.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.